Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
Recruiting now · Not applicable
Conditions studied: Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period, Postoperative Complications
In brief
This study aims to evaluate the impact of different extubation strategy on the occupancy time of operating room (OR) and the incidence of adverse events and quality of recovery after robotic-assisted surgery. The investigators hypothesize that extubation in the post-anesthesia care unit (PACU) may reduce OR occupancy time without increasing adverse events or worsening quality of recovery early after robotic-assisted surgery. This strategy may enhance perioperative efficiency while maintaining clinical safety.
Key facts
- Study ID
- NCT07332806
- Run by
- Peking University First Hospital
- People needed
- 218
- Starts
- 2026-01-12
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2026-01-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged ≥18 years;
- Scheduled to undergo elective robot-assisted laparoscopic surgery under general anesthesia;
- Expected tracheal extubation during daytime working hours (before 4:00 PM).
You may not qualify if…
- Refuse to participate in the study;
- Morbid obesity (body mass index ≥35 kg/m²);
- Preoperatively diagnosed obstructive sleep apnea, or patients with a STOP-Bang score ≥3 in combination with serum bicarbonate (HCO₃-) ≥28 mmol/L;
- Patients at high risk of difficult airway (anticipated difficult intubation and/or extubation during preoperative assessment);
- Preexisting sick sinus syndrome, severe sinus bradycardia (heart rate < 50 beats/min), or second-degree or higher atrioventricular block without pacemaker implantation; congenital heart disease with any type of arrhythmia; or other severe cardiovascular diseases with New York Heart Association (NYHA) functional class ≥III;
- Significant pulmonary function impairment (FEV₁/FVC ratio < 70%, and total lung capacity [TLC] and vital capacity [VC] < 80% of predicted values);
- Severe hepatic dysfunction (Child-Pugh class C); severe renal dysfunction (estimated glomerular filtration rate < 30 mL/min/1.73 m²); or American Society of Anesthesiologists (ASA) physical status classification ≥IV;
- Preoperative diagnoses of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis;
- Inability to communicate due to coma, severe dementia, or language impairment;
- Planned postoperative admission to the intensive care unit;
- Any other conditions that are deemed for study participation.
Where it is running
- Peking University Fist Hospital — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.